RANDALL K PEARSON, M.D.
Osteopathic Medicine at 1 St, Rochester, MN
License number
Minnesota 28971
Category
Osteopathic Medicine
Type
Gastroenterology
Address
Address
200 1St St SW, Rochester, MN 55905
Phone
(507) 284-2511
Organization information
See more information about RANDALL K PEARSON at bizstanding.comMayo Clinic - Randall K Pearson MD
200 1 St SW #W4, Rochester, MN 55905
Categories:
Gastroenterology Physicians & Surgeons, Internal Medicine Physicians & Surgeons, Physicians & Surgeons
Phone:
(507) 284-2468 (Phone)
Professional information
Dr. Randall K Pearson, Rochester MN - MD (Doctor of Medicine)
Specialties:
Gastroenterology
Address:
Mayo Clinic
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)
Certifications:
Gastroenterology, 1987, Internal Medicine, 1984
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Mayo Medical School
Graduated: 1981
Mayo Grad School Med/mayo Fndn
University Of Al Hospital
Mayo Medical School
Graduated: 1981
Mayo Grad School Med/mayo Fndn
University Of Al Hospital
Randall K Pearson, Rochester MN
Specialties:
Gastroenterologist
Address:
200 1St St Sw, Rochester, MN 55905
Education:
Mayo Clinic College of Medicine - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Gastroenterology (Internal Medicine)
Randall Keith Pearson, Rochester MN
Specialties:
Internal Medicine, Gastroenterology, Hepatology
Work:
Mayo Medical School
200 1St St Sw, Rochester, MN 55905 Mayo Clinic Health System-Faribault
300 State Ave, Faribault, MN 55021
200 1St St Sw, Rochester, MN 55905 Mayo Clinic Health System-Faribault
300 State Ave, Faribault, MN 55021
Education:
Mayo Medical School (1981)
Chemoprevention Of Metachronous Adenomatous Colorectal Polyps
US Patent:
5945411, Aug 31, 1999
Filed:
Sep 23, 1998
Appl. No.:
9/158871
Inventors:
Mark V. Larson - Elgin MN
David A. Ahlquist - Rochester MN
Randall K. Pearson - Rochester MN
David A. Ahlquist - Rochester MN
Randall K. Pearson - Rochester MN
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
A61K 3156
US Classification:
514171
Abstract:
A method for protecting a colorectum against a recurrence of adenomas is provided, wherein ursodeoxycholic acid or an amide-conjugate thereof, or ursodeoxycholic acid or an amide-conjugate thereof in combination with sulindac or a phenolic NSAID is administered to a patient afflicted with colorectal adenomas in an amount effective to prevent the recurrence of colorectal adenomas following the removal thereof.
Chemoprevention Of Metachronous Adenomatous Colorectal Polyps
US Patent:
5814625, Sep 29, 1998
Filed:
Sep 23, 1996
Appl. No.:
8/717556
Inventors:
Mark V. Larson - Elgin MN
David A. Ahlquist - Rochester MN
Randall K. Pearson - Rochester MN
David A. Ahlquist - Rochester MN
Randall K. Pearson - Rochester MN
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
A61K 3156
US Classification:
514171
Abstract:
A method for protecting a colorectum against a recurrence of adenomas is provided, wherein ursodeoxycholic acid or an amide-conjugate thereof, or ursodeoxycholic acid or an amide-conjugate thereof in combination with sulindac or a phenolic NSAID is administered to a patient afflicted with colorectal adenomas in an amount effective to prevent the recurrence of colorectal adenomas following the removal thereof.
Chemoprevention Of Metachronous Adenomatous Colorectal Polyps
US Patent:
5843929, Dec 1, 1998
Filed:
Mar 22, 1996
Appl. No.:
8/621781
Inventors:
Mark V. Larson - Elgin MN
David A. Ahlquist - Rochester MN
Randall K. Pearson - Rochester MN
David A. Ahlquist - Rochester MN
Randall K. Pearson - Rochester MN
Assignee:
Mayo Foundation for Medical Education and Research - Rochester NY
International Classification:
A61K 3156
US Classification:
514182
Abstract:
A method for protecting a colorectum against a recurrence of adenomomas is provided, wherein ursodeoxycholic acid, or ursodeoxycholic acid in combination with sulindac, is administered to a patient afflicted with colorectal adenomas in an amount effective to prevent the recurrence of colorectal adenomas following the removal thereof.